Key Takeaways
- • KKR acquires Integer Holdings for $5.7 billion in an all-cash deal, paying $127 per share—a 51.8% premium to Integer's April 29 closing price—and taking the medical device contract manufacturer private.
- • Integer, a Minnesota-based contract development and manufacturing organization (CDMO), generated approximately $1.8 billion in revenue last year with 11,000 employees; nearly half of its manufacturing footprint is concentrated in Minnesota across Brooklyn Park, Chaska, Minneapolis, and Plymouth facilities.
- • Integer supplies critical components including catheters, pacemaker batteries, and cardiac leads to major healthcare OEMs including Abbott, Boston Scientific, and Medtronic, positioning it as a foundational player in the U.S. medical device supply chain.
- • The acquisition signals KKR's confidence in medtech manufacturing consolidation and suggests institutional investors view Minnesota's medical-device supply chain infrastructure as a strategic consolidation opportunity with economies of scale potential.
- • Integer expects to gain operational flexibility and capital allocation authority under KKR ownership to reinvest in its contract development and manufacturing business, though any operational restructuring could have outsized local impact given the company's significant Minnesota employment base.
Summary
KKR completed its $5.7 billion acquisition of Integer Holdings in July 2026, acquiring the Texas-based contract development and manufacturing organization (CDMO) and transitioning it from public to private ownership. Shareholders received $127 per share in cash, representing a 51.8% premium to the company's closing price on April 29, the day prior to the deal announcement. The transaction represents one of the largest medtech manufacturing deals in recent years and underscores private equity's strategic interest in consolidating manufacturing infrastructure within the medical device supply chain.
Integer Holdings occupies a critical position in the North American medical device ecosystem. The company manufactures and supplies precision components—including catheters, pacemaker batteries, and cardiac leads—to the industry's largest original equipment manufacturers, including Abbott, Boston Scientific, and Medtronic. Last year, Integer generated approximately $1.8 billion in revenue and employed an estimated 11,000 people globally. The company traces its origins to 1970 when Wilson Greatbatch, inventor of the heart pacemaker battery, founded what was originally known as Greatbatch, Inc. Following a 2015 acquisition of Lake Region Medical, the company rebranded to Integer Holdings in 2016 and has pursued a strategy of horizontal consolidation to achieve economies of scale and reduce manufacturing costs.
Minnesota represents a disproportionately large concentration of Integer's manufacturing footprint, with nearly half of the company's operations based in the state across four facilities in Brooklyn Park, Chaska, Minneapolis, and Plymouth. This geographic concentration creates meaningful implications for the local industrial base and workforce. According to Muer Yang, a professor in the Department of Operations and Supply Chain Management at the University of St. Thomas Opus College of Business, Integer's historical strategy has focused on consolidation moves to drive cost efficiencies rather than transformative portfolio restructuring.
Under KKR ownership, Integer expects to gain operational flexibility and enhanced capital availability to invest in its contract development and manufacturing capabilities. The transaction signals a broader institutional investment thesis that Minnesota's medical-device supply chain represents a consolidation opportunity with significant value creation potential. Given Integer's deep integration with major OEMs and its substantial regional employment footprint, any operational changes or capital reallocation decisions by KKR could reverberate across Minnesota's medical device ecosystem.
Integer Holdings occupies a critical position in the North American medical device ecosystem. The company manufactures and supplies precision components—including catheters, pacemaker batteries, and cardiac leads—to the industry's largest original equipment manufacturers, including Abbott, Boston Scientific, and Medtronic. Last year, Integer generated approximately $1.8 billion in revenue and employed an estimated 11,000 people globally. The company traces its origins to 1970 when Wilson Greatbatch, inventor of the heart pacemaker battery, founded what was originally known as Greatbatch, Inc. Following a 2015 acquisition of Lake Region Medical, the company rebranded to Integer Holdings in 2016 and has pursued a strategy of horizontal consolidation to achieve economies of scale and reduce manufacturing costs.
Minnesota represents a disproportionately large concentration of Integer's manufacturing footprint, with nearly half of the company's operations based in the state across four facilities in Brooklyn Park, Chaska, Minneapolis, and Plymouth. This geographic concentration creates meaningful implications for the local industrial base and workforce. According to Muer Yang, a professor in the Department of Operations and Supply Chain Management at the University of St. Thomas Opus College of Business, Integer's historical strategy has focused on consolidation moves to drive cost efficiencies rather than transformative portfolio restructuring.
Under KKR ownership, Integer expects to gain operational flexibility and enhanced capital availability to invest in its contract development and manufacturing capabilities. The transaction signals a broader institutional investment thesis that Minnesota's medical-device supply chain represents a consolidation opportunity with significant value creation potential. Given Integer's deep integration with major OEMs and its substantial regional employment footprint, any operational changes or capital reallocation decisions by KKR could reverberate across Minnesota's medical device ecosystem.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.